Abstract
The CCR5 Delta32, CCR2 64I, SDF1 3'A, and CCR5 promoter 59029 polymorphisms have been suggested to influence HIV-1 disease progression. Furthermore, the CCR5 Delta32 and the CCR2 64I polymorphisms have been associated with various other diseases. The purpose of the present study was to develop a multiplex assay for the simultaneous determination of these four polymorphisms. Results obtained with the multiplex assay were compared to results obtained by conventional RFLP-PCR and no differences were observed. The multiplex assay offers a quick tool for the determination of the CCR5 Delta32, CCR2 64I, SDF1 3'A, and CCR5 promoter 59029 A/G polymorphisms.
| Original language | English |
|---|---|
| Journal | Journal of Immunological Methods |
| Volume | 252 |
| Issue number | 1-2 |
| Pages (from-to) | 147-51 |
| Number of pages | 5 |
| ISSN | 0022-1759 |
| DOIs | |
| Publication status | Published - 2001 |
Keywords
- Chemokine CXCL12
- Chemokines, CXC
- Disease Progression
- HIV Infections
- HIV-1
- Humans
- Polymerase Chain Reaction
- Polymorphism, Genetic
- Receptors, CCR2
- Receptors, CCR5
- Receptors, Chemokine
Fingerprint
Dive into the research topics of 'A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS